- REPORT SUMMARY
- TABLE OF CONTENTS
-
According to Maia’s survey, most of the sales channels for prescription drugs are still hospitals and clinics. The sales through clinics accounted for 50.36% in 2019, and the sales through hospitals accounted for 35.05%.
The report details the trend, potential and market size of Prescription Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Prescription Drugsmarket, defines the market attractiveness level of Prescription Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Prescription Drugs industry, describes the types of Prescription Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Prescription Drugs market and the development prospects and opportunities of Prescription Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Prescription Drugs market in Chapter 13.
By Player:
Takeda Pharmaceutical
AbbVie, Inc
GlaxoSmithKline PLC
Bristol-Myers Squibb Company
Allergan PLC
Pfizer, Inc
Novo Nordisk A/S
Novartis International AG
F Hoffmann-La Roche AG
Boehringer Ingelheim GmbH
Bayer AG
AstraZeneca PLC
Celgene Corporation
Merck & Co, Inc
Teva Pharmaceutical
Johnson & Johnson
Gilead Sciences, Inc
Amgen, Inc
Eli Lilly and Company
Sanofi
By Type:
Brand Drugs
Generic Drug
By End-User:
Online Sales
Hospital
Clinic
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Prescription Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Prescription Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Prescription Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Prescription Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Prescription Drugs Market Analysis and Outlook to 2022
-
7.1 Global Prescription Drugs Consumption (2017-2022)
-
7.2 United States Prescription Drugs Consumption (2017-2022)
-
7.3 Europe Prescription Drugs Consumption (2017-2022)
-
7.4 China Prescription Drugs Consumption (2017-2022)
-
7.5 Japan Prescription Drugs Consumption (2017-2022)
-
7.6 India Prescription Drugs Consumption (2017-2022)
-
7.7 South Korea Prescription Drugs Consumption (2017-2022)
8 Region and Country-wise Prescription Drugs Market Analysis and Outlook to 2028
-
8.1 Global Prescription Drugs Consumption Forecast (2022-2028)
-
8.2 United States Prescription Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Prescription Drugs Consumption Forecast (2022-2028)
-
8.4 China Prescription Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Prescription Drugs Consumption Forecast (2022-2028)
-
8.6 India Prescription Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Prescription Drugs Consumption Forecast (2022-2028)
9 Global Prescription Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Prescription Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Brand Drugs Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Generic Drug Consumption and Growth Rate (2017-2022)
-
9.2 Global Prescription Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Online Sales Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Other Consumption and Growth Rate (2017-2022)
10 Global Prescription Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Prescription Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Brand Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Generic Drug Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Prescription Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Online Sales Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Prescription Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Prescription Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Prescription Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Prescription Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Prescription Drugs Market Competitive Analysis
-
14.1 Takeda Pharmaceutical
-
14.1.1 Takeda Pharmaceutical Company Details
-
14.1.2 Takeda Pharmaceutical Prescription Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Takeda Pharmaceutical Prescription Drugs Product and Service
-
14.2 AbbVie, Inc
-
14.2.1 AbbVie, Inc Company Details
-
14.2.2 AbbVie, Inc Prescription Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 AbbVie, Inc Prescription Drugs Product and Service
-
14.3 GlaxoSmithKline PLC
-
14.3.1 GlaxoSmithKline PLC Company Details
-
14.3.2 GlaxoSmithKline PLC Prescription Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 GlaxoSmithKline PLC Prescription Drugs Product and Service
-
14.4 Bristol-Myers Squibb Company
-
14.4.1 Bristol-Myers Squibb Company Company Details
-
14.4.2 Bristol-Myers Squibb Company Prescription Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Bristol-Myers Squibb Company Prescription Drugs Product and Service
-
14.5 Allergan PLC
-
14.5.1 Allergan PLC Company Details
-
14.5.2 Allergan PLC Prescription Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Allergan PLC Prescription Drugs Product and Service
-
14.6 Pfizer, Inc
-
14.6.1 Pfizer, Inc Company Details
-
14.6.2 Pfizer, Inc Prescription Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Pfizer, Inc Prescription Drugs Product and Service
-
14.7 Novo Nordisk A/S
-
14.7.1 Novo Nordisk A/S Company Details
-
14.7.2 Novo Nordisk A/S Prescription Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Novo Nordisk A/S Prescription Drugs Product and Service
-
14.8 Novartis International AG
-
14.8.1 Novartis International AG Company Details
-
14.8.2 Novartis International AG Prescription Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Novartis International AG Prescription Drugs Product and Service
-
14.9 F Hoffmann-La Roche AG
-
14.9.1 F Hoffmann-La Roche AG Company Details
-
14.9.2 F Hoffmann-La Roche AG Prescription Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 F Hoffmann-La Roche AG Prescription Drugs Product and Service
-
14.10 Boehringer Ingelheim GmbH
-
14.10.1 Boehringer Ingelheim GmbH Company Details
-
14.10.2 Boehringer Ingelheim GmbH Prescription Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Boehringer Ingelheim GmbH Prescription Drugs Product and Service
-
14.11 Bayer AG
-
14.11.1 Bayer AG Company Details
-
14.11.2 Bayer AG Prescription Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Bayer AG Prescription Drugs Product and Service
-
14.12 AstraZeneca PLC
-
14.12.1 AstraZeneca PLC Company Details
-
14.12.2 AstraZeneca PLC Prescription Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 AstraZeneca PLC Prescription Drugs Product and Service
-
14.13 Celgene Corporation
-
14.13.1 Celgene Corporation Company Details
-
14.13.2 Celgene Corporation Prescription Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Celgene Corporation Prescription Drugs Product and Service
-
14.14 Merck & Co, Inc
-
14.14.1 Merck & Co, Inc Company Details
-
14.14.2 Merck & Co, Inc Prescription Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 Merck & Co, Inc Prescription Drugs Product and Service
-
14.15 Teva Pharmaceutical
-
14.15.1 Teva Pharmaceutical Company Details
-
14.15.2 Teva Pharmaceutical Prescription Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.15.3 Teva Pharmaceutical Prescription Drugs Product and Service
-
14.16 Johnson & Johnson
-
14.16.1 Johnson & Johnson Company Details
-
14.16.2 Johnson & Johnson Prescription Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.16.3 Johnson & Johnson Prescription Drugs Product and Service
-
14.17 Gilead Sciences, Inc
-
14.17.1 Gilead Sciences, Inc Company Details
-
14.17.2 Gilead Sciences, Inc Prescription Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.17.3 Gilead Sciences, Inc Prescription Drugs Product and Service
-
14.18 Amgen, Inc
-
14.18.1 Amgen, Inc Company Details
-
14.18.2 Amgen, Inc Prescription Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.18.3 Amgen, Inc Prescription Drugs Product and Service
-
14.19 Eli Lilly and Company
-
14.19.1 Eli Lilly and Company Company Details
-
14.19.2 Eli Lilly and Company Prescription Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.19.3 Eli Lilly and Company Prescription Drugs Product and Service
-
14.20 Sanofi
-
14.20.1 Sanofi Company Details
-
14.20.2 Sanofi Prescription Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.20.3 Sanofi Prescription Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Prescription Drugs
-
Figure Prescription Drugs Picture
-
Table Global Prescription Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Prescription Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Prescription Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Prescription Drugs Consumption by Country (2017-2022)
-
Figure United States Prescription Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Prescription Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Prescription Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Prescription Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Prescription Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Prescription Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Prescription Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Prescription Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Prescription Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Prescription Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Prescription Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Prescription Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Prescription Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Brand Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Generic Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Online Sales Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Brand Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Generic Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Online Sales Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Prescription Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Prescription Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Takeda Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Takeda Pharmaceutical Prescription Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Pharmaceutical Prescription Drugs Product and Service
-
Table AbbVie, Inc (Foundation Year, Company Profile and etc.)
-
Table AbbVie, Inc Prescription Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie, Inc Prescription Drugs Product and Service
-
Table GlaxoSmithKline PLC (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline PLC Prescription Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline PLC Prescription Drugs Product and Service
-
Table Bristol-Myers Squibb Company (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Company Prescription Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Company Prescription Drugs Product and Service
-
Table Allergan PLC (Foundation Year, Company Profile and etc.)
-
Table Allergan PLC Prescription Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergan PLC Prescription Drugs Product and Service
-
Table Pfizer, Inc (Foundation Year, Company Profile and etc.)
-
Table Pfizer, Inc Prescription Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer, Inc Prescription Drugs Product and Service
-
Table Novo Nordisk A/S (Foundation Year, Company Profile and etc.)
-
Table Novo Nordisk A/S Prescription Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novo Nordisk A/S Prescription Drugs Product and Service
-
Table Novartis International AG (Foundation Year, Company Profile and etc.)
-
Table Novartis International AG Prescription Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis International AG Prescription Drugs Product and Service
-
Table F Hoffmann-La Roche AG (Foundation Year, Company Profile and etc.)
-
Table F Hoffmann-La Roche AG Prescription Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann-La Roche AG Prescription Drugs Product and Service
-
Table Boehringer Ingelheim GmbH (Foundation Year, Company Profile and etc.)
-
Table Boehringer Ingelheim GmbH Prescription Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim GmbH Prescription Drugs Product and Service
-
Table Bayer AG (Foundation Year, Company Profile and etc.)
-
Table Bayer AG Prescription Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer AG Prescription Drugs Product and Service
-
Table AstraZeneca PLC (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca PLC Prescription Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca PLC Prescription Drugs Product and Service
-
Table Celgene Corporation (Foundation Year, Company Profile and etc.)
-
Table Celgene Corporation Prescription Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celgene Corporation Prescription Drugs Product and Service
-
Table Merck & Co, Inc (Foundation Year, Company Profile and etc.)
-
Table Merck & Co, Inc Prescription Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck & Co, Inc Prescription Drugs Product and Service
-
Table Teva Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Teva Pharmaceutical Prescription Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceutical Prescription Drugs Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Prescription Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Prescription Drugs Product and Service
-
Table Gilead Sciences, Inc (Foundation Year, Company Profile and etc.)
-
Table Gilead Sciences, Inc Prescription Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gilead Sciences, Inc Prescription Drugs Product and Service
-
Table Amgen, Inc (Foundation Year, Company Profile and etc.)
-
Table Amgen, Inc Prescription Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen, Inc Prescription Drugs Product and Service
-
Table Eli Lilly and Company (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly and Company Prescription Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly and Company Prescription Drugs Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Prescription Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Prescription Drugs Product and Service
-